-
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
12 Nov 2025 21:30 GMT
… ), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases … : KHINDIVI™, INCRELEX®, ALKINDI SPRINKLE®, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous …
-
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
06 Nov 2025 21:05 GMT
… innovative pharmaceutical company focused on developing and commercializing treatments for … by the FDA and assigned a Prescription Drug User … ranging and pivotal clinical trial in late 2026 … of discovering, developing and commercializing drugs that are safe …
-
FDA Eyes Accelerated Reviews for Gene Editing Therapies
03 Nov 2025 14:04 GMT
… bid to accelerate the development of drugs addressing rare conditions. … of a team successfully treating an extremely rare genetic … treatments in two more rare diseases, one for phenylketonuria … and designations, like the FDA’s recently announced Platform …
-
5 ways Halloween candies can interact with your medications — and cause dangerous side effects
01 Nov 2025 23:52 GMT
… of chocolate
Chocolate treats are consistently among … a senior lecturer in pharmacy practice at Kingston University … can supercharge stimulant medications used to treat ADHD, like … the rare genetic disorder phenylketonuria, potentially damaging brain cells …
-
FDA clears way for faster personalized gene editing therapy
01 Nov 2025 20:55 GMT
… FDA’s new approach. He predicted it will spark interest in developing treatments … Now, the FDA is allowing a combined trial of patients with … of the drug — the guide RNA — they could treat a … liver disorder known as phenylketonuria, or PKU, which can cause …
-
National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)
16 Oct 2025 11:00 GMT
… (ENB) candidate for the treatment of Phenylketonuria (PKU), a rare genetic disorder that … to expand access to treatments, accelerate the development of new therapies and … innovative approach holds promise for treating—and potentially curing—a wide …
-
FDA accepts pegvaliase-pqpz sBLA to expand treatment to patients with PKU aged 12-17 years
30 Oct 2025 02:11 GMT
…
FDA Priority Review accepted for pegvaliase-pqpz to treat … PKU. The trial included 2 parts:
Part 1: A primary treatment … can prevent major developmental complications, adherence to … 12-17 with Phenylketonuria. BioMarin Pharmaceutical Inc. Press release …
-
Five Halloween treats that can interact with your medications
30 Oct 2025 17:14 GMT
… raiding the treat bowl.
1. Chocolate
Chocolate treats are everywhere … diuretics, antiarrhythmic drugs, or blood pressure medication, and for … dangerous for people with phenylketonuria (PKU), a rare genetic disorder … dyes, so the treatment can end up feeding …
-
The surprising ways Halloween treats can interact with your medications
30 Oct 2025 14:12 GMT
… raiding the treat bowl.
1. Chocolate
Chocolate treats are everywhere … diuretics, antiarrhythmic drugs, or blood pressure medication, and for … dangerous for people with phenylketonuria (PKU), a rare genetic disorder … dyes, so the treatment can end up feeding …
-
Genescience discovers new SLC6A19 inhibitors for PKU
29 Oct 2025 18:13 GMT
Endocrine/metabolic
Genescience Pharmaceuticals Co. Ltd. has identified sodium- … to be useful for the treatment of phenylketonuria (PKU).
BioWorld Science Endocrine…